Hanns-Ulrich Marschall Selected Research

Fatty Acids (Saturated Fatty Acids)

1/2023	Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiring.
6/2015	Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.
3/2008	Role of short-chain hydroxyacyl CoA dehydrogenases in SCHAD deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanns-Ulrich Marschall Research Topics

Disease

24	Cholestasis 11/2023 - 12/2002
23	Liver Diseases (Liver Disease) 03/2024 - 12/2002
23	Fibrosis (Cirrhosis) 03/2024 - 02/2006
22	Intrahepatic Cholestasis of Pregnancy 11/2021 - 08/2004
21	Non-alcoholic Fatty Liver Disease 10/2023 - 09/2013
18	Sclerosing Cholangitis 01/2023 - 07/2004
17	Inflammation (Inflammations) 03/2024 - 02/2006
15	Pruritus (Itching) 01/2022 - 04/2003
11	Insulin Resistance 02/2024 - 01/2011
6	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 04/2015
5	Body Weight (Weight, Body) 03/2024 - 11/2005
5	Stillbirth 01/2021 - 03/2013
5	Dyslipidemias (Dyslipidemia) 01/2020 - 01/2011
4	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2024 - 01/2019
4	Obesity 10/2023 - 08/2011
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 09/2013
4	Type 2 Diabetes Mellitus (MODY) 07/2022 - 09/2013
4	Fatty Liver 01/2022 - 01/2011
3	Glucose Intolerance 03/2024 - 01/2018
3	Disease Progression 01/2023 - 07/2010
3	Digestive System Diseases 01/2023 - 10/2013
3	Neoplasms (Cancer) 01/2022 - 06/2014
3	Gallstones (Gallstone) 11/2019 - 05/2010
3	Diarrhea 01/2018 - 12/2006
3	Weight Loss (Weight Reduction) 01/2016 - 09/2013
3	Infarction (Infarctions) 02/2006 - 10/2002
2	Hyperbilirubinemia 11/2023 - 01/2006
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 02/2013
2	Intrahepatic Cholestasis 01/2022 - 01/2019
2	Autoimmune Hepatitis 01/2022 - 12/2017
2	Alcoholic Fatty Liver 01/2022 - 01/2018
2	Hyperglycemia 01/2022 - 01/2018
2	Premature Birth (Birth, Premature) 01/2021 - 01/2019
2	Cholangitis 01/2020 - 02/2006
2	Metabolic Diseases (Metabolic Disease) 01/2020 - 01/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2020
2	Bile Duct Diseases (Bile Duct Disease) 01/2018 - 01/2017
2	Hyperinsulinism (Hyperinsulinemia) 01/2018 - 03/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 08/2011
2	Cholelithiasis 07/2013 - 08/2004
1	Hyperlipidemias (Hyperlipidemia) 03/2024
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Colitis 01/2023
1	Rickets (Rachitis) 08/2022
1	Avitaminosis (Vitamin Deficiency) 08/2022
1	Diabetes Mellitus 07/2022

Drug/Important Bio-Agent (IBA)

58	Bile Acids and Salts (Bile Acids)IBA 02/2024 - 12/2002
31	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2023 - 10/2002
17	LipidsIBA 07/2022 - 05/2010
11	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2011
11	Proteins (Proteins, Gene)FDA Link 10/2023 - 02/2006
8	obeticholic acidIBA 01/2020 - 09/2013
7	Messenger RNA (mRNA)IBA 10/2023 - 03/2016
6	Phosphotransferases (Kinase)IBA 10/2023 - 01/2021
6	Progesterone FDA LinkGeneric 01/2022 - 02/2008
6	Rifampin (Rifampicin)FDA LinkGeneric 11/2021 - 08/2005
6	CholesterolIBA 01/2021 - 05/2010
5	Protein Kinases (Protein Kinase)IBA 10/2023 - 01/2019
5	AcidsIBA 09/2021 - 06/2009
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020 - 07/2017
4	Insulin (Novolin)FDA Link 02/2024 - 09/2013
4	Transaminases (Aminotransferases)IBA 01/2023 - 04/2003
4	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2022 - 09/2013
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2005
4	Alanine Transaminase (SGPT)IBA 01/2019 - 09/2013
4	BilirubinIBA 08/2016 - 04/2003
3	Therapeutic UsesIBA 03/2024 - 06/2009
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 03/2008
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2021 - 05/2006
3	Antisense OligonucleotidesIBA 01/2021 - 01/2018
3	LigandsIBA 01/2020 - 08/2005
3	Cholic AcidIBA 01/2020 - 08/2011
3	Alkaline PhosphataseIBA 08/2016 - 04/2015
3	EnzymesIBA 09/2013 - 08/2005
3	Cholestyramine Resin (Questran)FDA LinkGeneric 08/2011 - 04/2003
3	Dexamethasone (Maxidex)FDA LinkGeneric 02/2008 - 04/2003
2	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2016
2	Sulfates (Sulfates, Inorganic)IBA 01/2022 - 04/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 03/2006
2	Triglycerides (Triacylglycerol)IBA 10/2019 - 08/2011
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2016
2	ORALIT (ORS)IBA 02/2017 - 10/2013
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2017 - 11/2013
2	Indicators and Reagents (Reagents)IBA 04/2016 - 11/2010
2	24-norursodeoxycholic acidIBA 06/2009 - 02/2006
2	Glutathione (Reduced Glutathione)IBA 08/2007 - 12/2002
1	Polysaccharides (Glycans)IBA 03/2024
1	beta-GlucansIBA 03/2024
1	(1-3)(1-4)- beta-glucanIBA 03/2024
1	sodium-bile acid cotransporterIBA 11/2023
1	LipopolysaccharidesIBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Phospholipases (Phospholipase)IBA 01/2023
1	teduglutideIBA 01/2023
1	oligofructoseIBA 01/2023

Therapy/Procedure

17	Therapeutics 11/2023 - 02/2006
7	Liver Transplantation 01/2022 - 07/2010
4	Ligation 11/2023 - 01/2017
2	Transplantation 01/2023 - 01/2020
2	Bariatric Surgery 01/2016 - 01/2011